imbruvica
Imbruvica Approved to Treat Waldenström Macroglobulinemia With Rituxan
The FDA approved the use of ibrutinib (Imbruvica, Pharmacyclics/Janssen) in combination with rituximab ...
AUGUST 30, 2018
FDA Approves Imbruvica to Treat Adults With Chronic GVHD
Imbruvica becomes the first and only therapy specifically approved for adults with cGVHD, a serious and ...
AUGUST 7, 2017
FDA Grants New Indication for Imbruvica for Marginal Zone Lymphoma
Prior to this indication, there were no FDA-approved therapies specifically for this disease.
JANUARY 19, 2017
Load more